Donald Trump has rescinded an executive order from President Joe Biden that sought to lower the price of drugs.

The U.S. Centers for Medicare and Medicaid Services on Friday said it would not appeal a court order that it recalculate the ...

Many of the 61 million Americans with Medicare are wondering whether their out-of-pocket health costs will be higher in 2025 ...

As the next round of Medicare drug pricing negotiations get underway, experts predict President Trump may seek to weaken the program.

The new Trump administration should seize the opportunity to change the Medicare drug price negotiation program by ...

On its last weekday in power, the Biden Administration has chosen the next batch of drugs up for price negotiation in ...

The General Enrollment Period provides an opportunity to make up for a past oversight — the failure to enroll in Part B.

Trump’s executive order halts an effort to cap the copayment for generic medications at $2 for Medicare beneficiaries.

The Trump administration came into office earlier this week with a promise of cutting down on government spending and driving ...

Just how much Medicare price negotiations will negatively impact Novo Nordisk, though, depends on what the final negotiated ...

UnitedHealth Group Inc. promoted the head of its Medicare health plan business to lead the company’s broader insurance ...

The Biden administration announced Friday that Ozempic, Wegovy and 13 additional drugs will now be covered under Medicare ...